MORGAN STANLEY - 4D PHARMA PLC ownership

4D PHARMA PLC's ticker is LBPS and the CUSIP is 35085K109. A total of 11 filers reported holding 4D PHARMA PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of 4D PHARMA PLC
ValueSharesWeighting
Q2 2022$7,000
-96.7%
4,360
-89.9%
0.00%
Q1 2022$210,000
+84.2%
43,363
+108.8%
0.00%
Q4 2021$114,000
+111.1%
20,769
+138.0%
0.00%
Q3 2021$54,000
-76.7%
8,728
-59.5%
0.00%
Q2 2021$232,000
-8.3%
21,540
+0.8%
0.00%
Q1 2021$253,00021,3690.00%
Other shareholders
4D PHARMA PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Kepos Capital LP 100,000$483,0000.04%
Ruffer LLP 195,954$945,0000.02%
OSAIC HOLDINGS, INC. 4,274$21,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
WOLVERINE ASSET MANAGEMENT LLC 8,055$38,0000.00%
MORGAN STANLEY 43,363$210,0000.00%
Citadel Advisors 31,538$152,0000.00%
CAPSTONE INVESTMENT ADVISORS, LLC 15,200$73,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11,845$57,0000.00%
Tower Research Capital LLC (TRC) 8,506$41,0000.00%
View complete list of 4D PHARMA PLC shareholders